Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro

American Journal of Kidney Diseases

Volumn 30, Issue 5, 1997, Pages 680-689

  Sundaram, Sumuk ^b   Cendoroglo, Miguel ^b   Cooker, Laurinda A ^b   Jaber, Bertrand L ^b   Faict, Dirk ^b   Holmes, Clifford J ^b   Pereira, Brian J G ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Biocompatibility; Monocytes; Neutrophils; Novel fluids; Peritoneal dialysis; Sterilization

Indexed keywords

BICARBONATE; CYTOKINE; DIALYSIS FLUID; LACTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHEMICAL COMPOSITION; FILTRATION; HEATING; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PERITONEAL DIALYSIS; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; RESPIRATORY BURST; STAPHYLOCOCCUS AUREUS;

EID: 0030668276     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90493-5     Document Type: Article

References (44)

1. Nolph KD: Has peritoneal dialysis peaked? The impact of the CANUSA study. ASAIO J 23:136-138, 1996
2. Holmes CJ: Peritoneal host defense mechanisms in peritoneal dialysis. [Review]. Kidney Int Suppl 48:S58-70, 1994
3. Dobbie JW: Pathology of the peritoneum, in SB (ed): The Peritoneum and Peritoneal Access. London, UK, Butterworth & Co, 1992, pp 42-52
4. Dobbie JW: Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 12:14-27, 1993
5. Rippe B: Pathophysiological description of the ultrastructural changes of the peritoneal membrane during long-term continuous ambulatory peritoneal dialysis. Blood Purif 12:211-220, 1994
6. Holmes CJ: Biocompatibility of peritoneal dialysis solutions. Perit Dial Int 13:88-94, 1993 (editorial; comment)
7. Topley N, Williams JD: Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int 46:S71-S78, 1994
8. Rubin J, Lin LM, Lewis R, Cruse J, Bower JD: Host defense mechanisms in continuous ambulatory peritoneal dialysis. Clin Nephrol 20:140-144, 1983
9. Holmes CJ, Lewis S: Host defense mechanisms in the peritoneal cavity of continuous ambulatory dialysis patients 2. Humoral defenses. Pent Dial Int 11:112-117, 1991
10. Jörres A, Gahl GM: Effect of peritoneal dialysis fluids on leukocyte function. Pent Dial Int 14:S29-S32, 1994
11. Jörres A, Gahl GM, Frei U: Peritoneal dialysis fluid biocompatibility: Does it really matter? [Review]. Kidney Int Suppl 48:S79-86, 1994
12. Daniels I, Lindsay M, Porter C, Haynes AP, Fletcher J, Morgan AG: Effect of peritoneal dialysis effluent on superoxide anion production by polymorphonuclear neutrophils. Nephron 64:382-387, 1993
13. Dobos GJ, Bohler J, Zhou XJ, Andre M, Norgauer J, Kownatzki E, Schollmeyer PJ, Vaziri ND: Persistent inhibition of neutrophil function by glucose based dialysis solutions. ASAIO J 40:M435-M439, 1994
14. Liberek T, Topley N, Jörres A, Coles GA, Gahl GM, Williams JD: Peritoneal dialysis fluid inhibition of phagocyte function: Effects of osmolality and glucose concentration. J Am Soc Nephrol 3:1508-1515, 1993
15. Liberek T, Topley N, Jörres A, Petersen MM, Coles GA, Gahl GM, Williams GD: Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 65:260-265, 1993
16. Jörres A, Jörres D, Gahl GM, Kessel M, Muller C, Kottgen E, Serke S, Schulz E, Mahiout A: Leukotriene B4 and tumor necrosis factor release from leukocytes: Effect of peritoneal dialysate. Nephron 58:276-282, 1991
17. Witowski J, Topley N, Jörres A, Liberek T, Coles GA, Williams JD: Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 46:282-293, 1994
18. Liberek T, Topley N, Mistry CD, Coles GA, Morgan T, Quirk RA, Williams JD: Cell function and viability in glucose polymer peritoneal dialysis fluids [see comments]. Perit Dial Int 13:104-111, 1993
19. Brulez HF, Heezius EC, de Fijter CW, Oe LP, Verhoef J, Verbrugh HA: In vitro compatibility of a 1.1% amino acid containing peritoneal dialysis fluid with phagocyte function. Adv Perit Dial 10:241-244, 1994
20. de Fijter CW, Verbrugh HA, Oe LP, Heezius E, Donker AJ, Verhoef J, Gokal R: Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid. Am J Kidney Dis 21:411-418, 1993
21. Breborowicz A, Oreopoulos D: Physiological approaches to increase biocompatibility of peritoneal dialysis. [Review]. Perit Dial Int 15:S85-S86, 1995
22. Topley N, Kaur D, Petersen MN, Jörres A, Faict D, Williams JD, Holmes CJ: In vitro effects of bicarbonate and bicarbonate/lactate buffered peritoneal dialysis solutions on mesothelial cell and neutrophil function. J Am Soc Nephrol 7:218-224, 1996
23. Pedersen FB: Biocompatibility studies with bicarbonate-based solutions. Adv Perit Dial 10:245-250, 1994
24. Weislander AP, Linden T: Glucose degradation and cytotoxicity in PD fluids. Perit Dial Int 16:S114-S118, 1996
25. Wieslander AP, Kjellstrand PT, Rippe B: Heat sterilization of glucose-containing fluids for peritoneal dialysis: Biological consequences of chemical alterations [Review]. Perit Dial Int 15:859-60, 1995
26. Nilsson-Thorell CB, Muscalu N, Andren AHG, Kjellstrand PTT, Wieslander AP: Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 13:208-213, 1993
27. Wieslander AP, Deppisch R, Svensson E, Forsback G, Speidel R, Rippe B: In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis. Pent Dial Int 15:158-164, 1995
28. Wing WT: An examination of the decomposition of dextrose solution during sterilisation. J Pharm Pharmacol 12:191T-196T, 1960
29. Ing TS, Yu AW, Thomas AU, Ansari AU, McShane AP, Gandhi VC, Filkins JP: Peritoneal dialysis using conventional lactate containing solutions sterilized by ultrafiltration. Int J Artif Organs 15/11:658-660, 1992
30. Cook AP, MacLeod TM, Applton JD, Fell AF: Reversed-phase high performance liquid chromatographic method for quantification of 5-hydroxymethylfurfural as the major degradation product of glucose in infusion fluids. Chromosoma 21:395-401, 1989
31. Martinson E, Wieslander A, Kjellstrand P, Boberg U: Toxicity in heat-sterilized fluids for peritoneal dialysis derives from degradation of glucose. ASAIO Trans 100-109, 1992
32. Pereira BJG, Poutsiaka D, King AJ, Strom JA, Narayan G, Levey AS, Dinarello CA: In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Kidney Int 42:1419-1424, 1992
33. Boyum A: Isolation of mononuclear cells and granulocytes from human blood: Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 97:77-89, 1968 (suppl)
34. Pereira BJG, King AJ, Falgas ME, Shapiro L, Strom JA, Dinarello CA: Plasma levels of IL-1, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890-896, 1994
35. Klempner MS, Noring R, Mier JW, Atkins MB: An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy. N Engl J Med 322:959-965, 1990
36. Metcalf JA, Gallin JI, Nauseef WM, Root RK: Laboratory Manual of Neutrophil Function. New York, NY, Raven Press, 1986
37. Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW: Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J Immunol 144:662-666, 1990
38. Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW: The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 148:532-537, 1992
39. Cooker LA, Luneberg P, Faict D, Choo C, Holmes CJ: Reduced glucose degradation products in bicarbonate/ lactate-buffered peritoneal dialysis solutions. Pent Dial Int 1997 (in press)
40. Ahmed MI, Rawal PA, Patel NM, Yu AW, Abraham M, Harvey VC, Ing TS: In vitro buffering capacity of residual peritoneal dialysate fluid: Implications for peritoneal dialysis therapy. Artif Organs 16:416-418, 1992
41. de Fijter CWH, Verbrugh HA, Peters EDJ, Oe PL, van der Meulen J, Verhoef J, Donker AJ: In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages. Clin Nephrol 39:75-80, 1993
42. Zeigler-Heitbrock HWL: Molecular mechanisms to tolerance to lipopolysaccharide. Journal of Inflammation 45:13-26, 1995
43. Lin RY, Astiz ME, Saxon JC, Rackow EC: Altered leukocyte immunophenotypes in septic shock: Studies of HCA-DR, CD11b, CD14 and IL-2R expression. Chest S47-S53, 1993
44. Wieslander AP, Nordin MK, Martinson E, Kjellstrand PT, Boberg UC: Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin Nephrol 39:343-348, 1992